0001562180-19-002182.txt : 20190403 0001562180-19-002182.hdr.sgml : 20190403 20190403163054 ACCESSION NUMBER: 0001562180-19-002182 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190403 DATE AS OF CHANGE: 20190403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saccomano Nicholas A CENTRAL INDEX KEY: 0001609284 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16633 FILM NUMBER: 19729398 BUSINESS ADDRESS: BUSINESS PHONE: 303-381-6600 MAIL ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC CENTRAL INDEX KEY: 0001100412 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841460811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3033816600 MAIL ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-04-01 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001609284 Saccomano Nicholas A C/O ARRAY BIOPHARMA INC. 3200 WALNUT STREET BOULDER CO 80301 false true false false CSO Common Stock 2019-04-01 4 M false 13750.00 0.00 A 156238.00 D Common Stock 2019-04-01 4 F false 6048.00 24.60 D 150190.00 D Restricted Stock Units 0.00 2019-04-01 4 M false 6875.00 0.00 D Common Stock 6875.00 0.00 D Restricted Stock Units 0.00 2019-04-01 4 M false 6875.00 0.00 D Common Stock 6875.00 6875.00 D Shares issued upon settlement of Restricted Stock Units ("RSUs") granted on April 1, 2015 and April 1, 2016, as a result of the vesting of one fourth of such RSUs. Represents shares withheld to satisfy tax withholding obligations of the reporting person. The RSUs vested and settled in stock in four equal annual installments beginning April 1, 2015. The RSUs vest and will be settled in stock in four equal annual installments beginning April 1, 2016. Jason Haddock, attorney-in-fact for Nicholas A. Saccomano 2019-04-03